Adequan i.m. is the only FDA-approved treatment that reverses the effects of arthritis in the synovial joints of horses.

Adequan® i.m. polysulfated glycosaminoglycan (PSGAG) solution 100 mg/mL. Adequan ® i.m. is recommended for the intramuscular treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness of the carpal and hock joints in horses.

One common question that horse owners have when it comes to using Adequan is how often it should be given to their horse. In this article, we will explore the recommended dosing schedule for Adequan in horses, as well as some interesting trends related to this topic as it relates to pets.

Adequan i.m. Polysulphate glycosaminoglycan is recommended for the intramuscular treatment of non-infectious, degenerative, and/or traumatic joint dysfunction and associated lameness of the carpal and hawk joints in horses.

Adequan Equine I.M. treats degenerative joint dysfunction as well as non-infectious trauma arthritis, hock joint difficulties, and carpal lameness. It is an intramuscular injection for horses that contains polysulfated glycosaminoglycan. Please note that there are 7 vials in every package.

Nov 7, 2024 · Adequan injections can be a valuable tool in managing joint health in horses, particularly for those with osteoarthritis. Its ability to stimulate cartilage repair and reduce inflammation can significantly improve a horse’s comfort and mobility.

Adequan is an FDA-approved injectable medication prescribed for the treatment of equine non-infectious degenerative joint disease (DJD), specifically in the carpal and hock joints (the equivalent of the ankle bone in humans).

Dec 26, 2024 · Adequan dosage for horses is a crucial aspect of equine joint health management. Knowing the correct dosage and administration guidelines is essential for effectively treating joint inflammation and maintaining your horse’s mobility and comfort.

Jul 7, 2023 · Adequan® i.m. has emerged as a valuable treatment option for horses with joint dysfunction, particularly in cases of degenerative joint diseases, such as osteoarthritis. Research suggests potential benefits for lameness scores, reduced …